What’s Next in Immuno-Oncology - A Visionary Conversation with Dr Ira Mellman

This podcast features a fireside chat between Dr Ira Mellman, PICI and Dr Axel Hoos, Former CEO, Scorpion Therapeutics from the 2026 Immuno-Oncology 360° conference. Drawing on Dr Mellman’s extensive experience and current work at the Parker Institute for Cancer Immunotherapy, this conversation provides:Insight into the scientific and clinical trajectory of immuno-oncologyPerspectives on the evolving role of collaboration and innovative partnership models like PICIDiscussion of the key opportunities and challenges shaping IO innovation at scaleA visionary outlook on what the next chapter of immuno-oncology could look likeTo learn more about the IO360° Summit, please visit https://www.io360summit.com/